ISSN: 2639-2178
Function of 5-Hydroxytryptamine Type 3 Receptors-A Computational Approach
This study investigates the function of 5-HT type 3 (5-HT3) receptors using a computational approach. Antagonists of the 5-HT3 receptor are currently one of the most effective therapeutic agents in treatment of chemotherapy-induced nausea, vomiting, and irritable bowel syndrome. Several experimental studies have shown the effect of pharmacological agents such as 9-tetrahydrocannabinol (THC), the psychoactive component of Cannabis, Cannabidiol (CBD), a non-psychoactive ingredient of Cannabis plant, Menthol, Propofol, and etc. on the functional human 5-HT3 receptors expressed in Xenopus oocyte as well as rat nodose ganglion neurons. 5-HT evoked currents recorded by a two-electrode clamp technique were inhibited by ligands in a concentration dependent manner. Simulations of allosteric inhibition were modeled using Vina docking techniques with the 5-HT3 structure. The 5-HT3 structure was found using homology sequence similarity techniques with the neuronal nicotinic acetylcholine receptor (nACH) and inhibitory neurotransmitter receptor for GABA (A). Results of studies with other members of the super family of ligand gated ion channels signified key residues involved in ligand binding sites within the transmembrane region of 5-HT3. Flexible and rigid docking simulations around key residues resulted in a number of low-energy (high affinity) configurations of ligand binding. The predicted residues TYR and THR may constitute a naturally occurring binding site for 5-HT3.
Keywords:
